Loading…
Breath-Ammonia Testing of Healthy Subjects and Patients with Cirrhosis
Background Hepatic encephalopathy (HE) is a serious neuropsychiatric complication in both acute and chronic liver disease. Aims To establish the utility of a portable noninvasive method to measure ammonia in the breath of healthy subjects and patients with HE. Methods The study included 106 subjects...
Saved in:
Published in: | Digestive diseases and sciences 2012, Vol.57 (1), p.189-195 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Hepatic encephalopathy (HE) is a serious neuropsychiatric complication in both acute and chronic liver disease.
Aims
To establish the utility of a portable noninvasive method to measure ammonia in the breath of healthy subjects and patients with HE.
Methods
The study included 106 subjects: 44 women and 62 men, 51 healthy and 55 cirrhotic. The breath ammonia was measured with an electrochemical sensor and expressed in parts/billion (ppb).
Results
The breath ammonia in healthy subjects had an average value of 151.4 ppb (95% confidence interval [CI]: 149.4–153.4) and the average value in cirrhotic patients was 169.9 ppb (95% CI: 163.5–176.2) (
P
|
---|---|
ISSN: | 0163-2116 1573-2568 |
DOI: | 10.1007/s10620-011-1858-9 |